Balyasny Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-49,497
| Closed | -$798K | – | 2310 |
|
|
2024
Q3 | $798K | Buy |
+49,497
| New | +$798K | ﹤0.01% | 1388 |
|
|
2023
Q2 | – | Sell |
-1,631
| Closed | -$68K | – | 2237 |
|
|
2023
Q1 | $68K | Buy |
1,631
+940
| +136% | +$39.2K | ﹤0.01% | 1915 |
|
|
2022
Q4 | $23.4K | Buy |
+691
| New | +$23.4K | ﹤0.01% | 2024 |
|
|
2022
Q3 | – | Sell |
-788
| Closed | -$31K | – | 2700 |
|
|
2022
Q2 | $31K | Buy |
+788
| New | +$31K | ﹤0.01% | 1969 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1527 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1712 |
|
|
2018
Q2 | – | Sell |
-755
| Closed | -$231K | – | 1864 |
|
|
2018
Q1 | $231K | Sell |
755
-77
| -9% | -$23.6K | ﹤0.01% | 1524 |
|
|
2017
Q4 | $245K | Buy |
+832
| New | +$245K | ﹤0.01% | 1576 |
|